Table 1 Baseline characteristics of different categories HVS in peritoneal dialysis patients with diabetes
All patients (n = 820) | HVS < 1/3 (n = 428) | 1/3 ≤ HVS < 2/3 (n = 254) | HVS ≥ 2/3 (n = 138) | p for tend | |
|---|---|---|---|---|---|
Age (years) | 56.9 ± 14.6 | 55.8 ± 14.9 | 58.2 ± 14.2 | 60.1 ± 13.7 | < 0.001 |
Sex, Male, n (%) | 424 (51.7) | 224 (52.3) | 130 (51.2) | 70 (50.2) | 0.706 |
Smoking, n (%) | 204 (24.6) | 102 (23.8) | 64 (25.2) | 38 (27.5) | 0.381 |
Drinking, n (%) | 112 (13.7) | 54 (12.6) | 36 (14.2) | 22 (15.9) | 0.328 |
Cardiovascular disease history, n (%) | 266 (32.4) | 136 (31.8) | 90 (35.4) | 40 (28.9) | 0.848 |
Hypertension, n (%) | 670 (81.7) | 354 (82.7) | 202 (79.5) | 114 (82.6) | 0.714 |
Drugs | |||||
Insulin, n (%) | 686 (83.7) | 362 (84.6) | 212 (83.5) | 112 (81.2) | 0.353 |
Statins, n (%) | 178 (21.7) | 98 (22.9) | 52 (20.5) | 28 (20.3) | 0.427 |
Antiplatelet, n (%) | 250 (30.5) | 112 (29.0) | 92 (36.2) | 34 (24.6) | 0.527 |
Hypertensive agent, n (%) | 666 (81.2) | 340 (79.4) | 214 (84.3) | 112 (81.2) | 0.370 |
Mean arterial pressure (mmHg) | 97.2 ± 12.1 | 96.6 ± 11.8 | 97.3 ± 12.0 | 97.8 ± 12.9 | 0.547 |
Body mass index (kg/m2) | 21.9 ± 3.5 | 21.6 ± 3.3 | 22.2 ± 3.6 | 22.8 ± 4.1 | 0.010 |
Mean time of diabetes history (years) | 15.5 ± 6.7 | 15.2 ± 5.1 | 15.6 ± 5.8 | 16.0 ± 7.1 | 0.153 |
Frequencies of HbA1c measurement (per patient) | 5.5 (4.6, 7.0) | 5.6 (4.3, 7.2) | 5.3 (4.2, 7.1) | 5.2 (4.0, 6.4) | 0.109 |
HbA1c at baseline (%) | 7.0 ± 2.3 | 6.8 ± 2.1 | 7.4 ± 2.8 | 8.0 ± 3.2 | < 0.001 |
HbA1c at baseline (mmol/mol) | 53.0 ± 24.6 | 51.1 ± 23.0 | 57.7 ± 30.2 | 64.3 ± 35.1 | < 0.001 |
Fasting blood-glucose (mmol/L) | 8.1 ± 2.7 | 7.8 ± 2.5 | 8.0 ± 2.8 | 8.2 ± 3.1 | 0.146 |
Hemoglobin (g/L) | 90.6 ± 10.4 | 88.8 ± 10.1 | 90.1 ± 10.5 | 92.3 ± 9.8 | < 0.001 |
Alanine aminotransferase (U/L) | 23.2 ± 8.0 | 22.9 ± 8.1 | 23.5 ± 7.8 | 24.1 ± 8.6 | 0.072 |
Serum albumin (g/L) | 35.0 ± 5.3 | 34.9 ± 5.1 | 35.0 ± 5.4 | 34.8 ± 5.2 | 0.807 |
High-density lipoprotein (mmol/L) | 1.4 ± 0.4 | 1.4 ± 0.4 | 1.4 ± 0.5 | 1.4 ± 0.5 | 0.143 |
Low-density lipoprotein (mmol/L) | 3.1 ± 1.2 | 3.0 ± 0.9 | 3.1 ± 1.1 | 3.2 ± 1.4 | 0.072 |
Intact parathyroid hormone (pg/ml) | 250 ± 110 | 254 ± 109 | 246 ± 127 | 259 ± 104 | 0.953 |
Residual renal function (ml/min) | 3.8 (1.2, 9.2) | 3.7 (1.1, 7.1) | 3.8 (1.6, 9.9) | 3.9 (1.8, 10.4) | 0.095 |
C-reactive protein (mg/L) | 5.9 (4.3, 8.0) | 5.8 (4.2, 7.5) | 6.1 (4.6, 7.8) | 6.4 (4.5, 8.3) | < 0.001 |
nPNA (g/kg/day) | 1.1 ± 0.2 | 1.1 ± 0.3 | 1.0 ± 0.2 | 1.1 ± 0.2 | 0.460 |
D/Pcr | 0.7 ± 0.2 | 0.7 ± 0.3 | 0.7 ± 0.1 | 0.7 ± 0.2 | 0.389 |
Total Kt/Vurea | 1.8 ± 0.5 | 1.8 ± 0.5 | 1.8 ± 0.4 | 1.8 ± 0.4 | 0.246 |